AI-Guided Patient-Derived Endothelial Modeling Identifies a Reversible Moyamoya-Specific miRNA Deficiency Corrected by Stem Cell-Extracellular Vesicles
Translational Stroke Research · 2026-06 · 17 (3)
DOI: 10.1007/s12975-026-01456-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 11.06.2026. Verfasst von Ji Hoon Bang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Computer Science, University of Georgia, Athens, GA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Endothelial Cells, Extracellular Vesicles, Induced Pluripotent Stem Cells. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by abnormal vascular remodeling and impaired angiogenesis. We profiled plasma extracellular vesicle (EV)–derived microRNAs (miRNAs) from MMD patients and healthy controls and generated patient-specific induced pluripotent stem cell–derived endothelial cells (iPSC-ECs) to investigate disease-associated molecular alterations and therapeutic reversibility. Both plasma EVs and iPSC-ECs from MMD patients showed significant depletion of angiogenesis-related miRNAs. Small RNA sequencing data revealed mesenchymal stem cell–derived EVs (MSC-EVs) contain a miRNA repertoire that substantially overlaps with miRNAs deficient in MMD. Treatment of MMD iPSC-ECs with MSC-EVs restored the majority of the depleted miRNAs to normal levels, normalized predicted target mRNA expression, and rescued angiogenic function in a dose-dependent manner, as demonstrated by tube formation assays. To improve identification of biologically relevant miRNA–mRNA interactions, we developed an artificial intelligence–based framework integrating experimentally validated databases, endothelial-focused literature mining, and large language model (LLM)–assisted mechanistic scoring. Incorporation of LLM–derived contextual features modestly improved prediction performance compared with conventional sequence-based models (baseline AUROC ~ 0.51; LLM-enhanced AUROC ~ 0.72), suggesting that literature-informed biological context provides meaningful signal beyond structural target features alone. Furthermore, our findings demonstrate that MSC-EV therapy can substantially reverse molecular and functional endothelial deficits. Integrated profiling and AI-driven interaction mapping together establish a hypothesis-generating framework (“Exo-Courier”) for biologically informed prioritization of EV-based therapeutic targets in vascular disorders. Graphical Abstract Comparative miRNA profiling of circulating extracellular vesicles from patients with Moyamoya disease and healthy controls identifies a disease-specific miRNA depletion signature. Predicted target mRNAs of these dysregulated miRNAs form a complex regulatory network implicated in endothelial dysfunction. Treatment with the Moyamoya disease–targeted extracellular vesicle therapy (SNE-101) restores miRNA levels and normalizes downstream mRNA expression, illustrating the therapeutic correction of disease-associated molecular pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computer Science, University of Georgia, Athens, GA, USA.
- S&E Bio, Inc, Seoul, Korea.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
- Department of Biomedical Sciences, College of Medical Convergence, Catholic Kwandong University, Gangneung-si, Gangwon-do, South Korea.
- S&E Bio, Inc, Seoul, Korea. nmboy@skku.edu.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea. nmboy@skku.edu.
Förderung
- Korean Fund for Regenerative Medicine
Zitieren
APA
Bang, J. H., Kim, J. E., Kim, E. H., Yang, H., Jang, J., & Bang, O. Y. (2026). AI-Guided Patient-Derived Endothelial Modeling Identifies a Reversible Moyamoya-Specific miRNA Deficiency Corrected by Stem Cell-Extracellular Vesicles. Translational Stroke Research, 17(3). https://doi.org/10.1007/s12975-026-01456-3
Vancouver
Bang JH, Kim JE, Kim EH, Yang H, Jang J, Bang OY. AI-Guided Patient-Derived Endothelial Modeling Identifies a Reversible Moyamoya-Specific miRNA Deficiency Corrected by Stem Cell-Extracellular Vesicles. Translational Stroke Research. 2026;17(3). doi:10.1007/s12975-026-01456-3
BibTeX
@article{Bang2026,
author = {Bang, Ji Hoon and Kim, Ji Eun and Kim, Eun Hee and Yang, Hyeock and Jang, Jiho and Bang, Oh Young},
title = {AI-Guided Patient-Derived Endothelial Modeling Identifies a Reversible Moyamoya-Specific miRNA Deficiency Corrected by Stem Cell-Extracellular Vesicles},
journal = {Translational Stroke Research},
year = {2026},
volume = {17},
number = {3},
doi = {10.1007/s12975-026-01456-3}
}
EUVIMED